Found: 41
Select item for more details and to access through your institution.
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Transferrin-Conjugated SNALPs Encapsulating 2'-O-Methylated miR-34a for the Treatment of Multiple Myeloma.
- Published in:
- BioMed Research International, 2014, v. 2014, p. 1, doi. 10.1155/2014/217365
- By:
- Publication type:
- Article
Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.
- Published in:
- Scientific Reports, 2015, v. 5, n. 1, p. 17579, doi. 10.1038/srep17579
- By:
- Publication type:
- Article
Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 2, p. 189, doi. 10.3390/cells11020189
- By:
- Publication type:
- Article
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2018, v. 37, n. 1, p. N.PAG, doi. 10.1186/s13046-018-0767-6
- By:
- Publication type:
- Article
Reprogramming Tumor-Immune Cell Interface in Solid and Hematological Malignancies to Enhance Response to Therapy.
- Published in:
- 2018
- By:
- Publication type:
- Proceeding
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 17, p. 13485, doi. 10.3390/ijms241713485
- By:
- Publication type:
- Article
The New Microtubule-Targeting Agent SIX2G Induces Immunogenic Cell Death in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810222
- By:
- Publication type:
- Article
Mitochondrial RNAs as Potential Biomarkers of Functional Impairment in Diabetic Kidney Disease.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 15, p. 8198, doi. 10.3390/ijms23158198
- By:
- Publication type:
- Article
Circulating Coding and Long Non-Coding RNAs as Potential Biomarkers of Idiopathic Pulmonary Fibrosis.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 22, p. 8812, doi. 10.3390/ijms21228812
- By:
- Publication type:
- Article
Uncharacterized RNAs in Plasma of Alzheimer's Patients Are Associated with Cognitive Impairment and Show a Potential Diagnostic Power.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 20, p. 7644, doi. 10.3390/ijms21207644
- By:
- Publication type:
- Article
DMET-Analyzer: automatic analysis of Affymetrix DMET Data.
- Published in:
- BMC Bioinformatics, 2012, v. 13, n. 1, p. 258, doi. 10.1186/1471-2105-13-258
- By:
- Publication type:
- Article
Hit identification of novel small molecules interfering with MALAT1 triplex by a structure‐based virtual screening.
- Published in:
- Archiv der Pharmazie, 2023, v. 356, n. 8, p. 1, doi. 10.1002/ardp.202300134
- By:
- Publication type:
- Article
TERRA G-quadruplex stabilization as a new therapeutic strategy for multiple myeloma.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2023, v. 42, n. 1, p. 1, doi. 10.1186/s13046-023-02633-0
- By:
- Publication type:
- Article
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic "dark matter".
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01622-x
- By:
- Publication type:
- Article
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01468-8
- By:
- Publication type:
- Article
In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
- Published in:
- British Journal of Haematology, 2008, v. 143, n. 4, p. 520, doi. 10.1111/j.1365-2141.2008.07387.x
- By:
- Publication type:
- Article
<i>In Vivo</i> Activity of MiR-34a Mimics Delivered by Stable Nucleic Acid Lipid Particles (SNALPs) against Multiple Myeloma.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0090005
- By:
- Publication type:
- Article
<i>In Vitro</i> and <i>In Vivo</i> Activity of a Novel Locked Nucleic Acid (LNA)-Inhibitor-miR-221 against Multiple Myeloma Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0089659
- By:
- Publication type:
- Article
UMG1/CD3ε‐bispecific T‐cell engager redirects T‐cell cytotoxicity against diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 2, p. 555, doi. 10.1111/bjh.19183
- By:
- Publication type:
- Article
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-019-0714-9
- By:
- Publication type:
- Article
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1647, doi. 10.3390/cancers15061647
- By:
- Publication type:
- Article
Molecular Characterization of Cancer Associated Fibroblasts in Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2943, doi. 10.3390/cancers14122943
- By:
- Publication type:
- Article
miR-22 Modulates Lenalidomide Activity by Counteracting MYC Addiction in Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 17, p. 4365, doi. 10.3390/cancers13174365
- By:
- Publication type:
- Article
miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 7, p. 1587, doi. 10.3390/cancers13071587
- By:
- Publication type:
- Article
Alternative Non-Homologous End-Joining: Error-Prone DNA Repair as Cancer's Achilles' Heel.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1392, doi. 10.3390/cancers13061392
- By:
- Publication type:
- Article
Allometric Scaling Approaches for Predicting Human Pharmacokinetic of a Locked Nucleic Acid Oligonucleotide Targeting Cancer-Associated miR-221.
- Published in:
- Cancers, 2020, v. 12, n. 1, p. 27, doi. 10.3390/cancers12010027
- By:
- Publication type:
- Article
Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case‐Control Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2019, v. 106, n. 2, p. 422, doi. 10.1002/cpt.1391
- By:
- Publication type:
- Article
A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells.
- Published in:
- Journal of Cellular Physiology, 2014, v. 229, n. 12, p. 2106, doi. 10.1002/jcp.24669
- By:
- Publication type:
- Article
miR-29b negatively regulates human osteoclastic cell differentiation and function: Implications for the treatment of multiple myeloma-related bone disease.
- Published in:
- Journal of Cellular Physiology, 2013, v. 228, n. 7, p. 1506, doi. 10.1002/jcp.24306
- By:
- Publication type:
- Article
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes.
- Published in:
- Microarrays (2076-3905), 2016, v. 5, n. 4, p. 24, doi. 10.3390/microarrays5040024
- By:
- Publication type:
- Article
Error‐prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 10, p. 2658, doi. 10.1002/ijc.33038
- By:
- Publication type:
- Article
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Chromene Derivatives as Selective TERRA G-Quadruplex RNA Binders with Antiproliferative Properties.
- Published in:
- Pharmaceuticals (14248247), 2022, v. 15, n. 5, p. 548, doi. 10.3390/ph15050548
- By:
- Publication type:
- Article
From single gene analysis to single cell profiling: a new era for precision medicine.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2020, v. 39, n. 1, p. 1, doi. 10.1186/s13046-020-01549-3
- By:
- Publication type:
- Article
Correction to: Cell communication and signaling: how to turn bad language into positive one.
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1337-2
- By:
- Publication type:
- Article
Cell communication and signaling: how to turn bad language into positive one.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1122-2
- By:
- Publication type:
- Article
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2019, v. 38, n. 1, p. N.PAG, doi. 10.1186/s13046-019-1056-8
- By:
- Publication type:
- Article
Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice.
- Published in:
- CTS: Clinical & Translational Science, 2021, v. 14, n. 1, p. 113, doi. 10.1111/cts.12869
- By:
- Publication type:
- Article